Superworth

NEUROONE MEDICAL TECHNOLOGIES EPS NMTC

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.92
Latest quarter, Q3 FY26
−$0.28
Fiscal year 2025
−$0.45

NEUROONE MEDICAL TECHNOLOGIES' earnings per share was −$0.92 over the twelve months to Jun 30, 2026.

In its latest quarter, Q3 FY26, it was −$0.28.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.45n/a
FY2024−$2.76n/a
FY2023−$3.96n/a
FY2022−$3.72n/a
FY2021−$5.64n/a
FY2020−$16.32n/a
FY2019−$10.44n/a
FY2018−$14.58n/a
FY2017−$13.50n/a
FY2016−$0.18n/a
FY2015$0.00n/a
FY2014$0.00n/a
FY2013$0.00n/a
FY2012$0.00n/a
FY2011n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q3 FY26−$0.28n/a−$0.92
Q2 FY26−$0.28n/a−$0.83
Q1 FY26−$0.18−150%−$0.99
Q4 FY25−$0.18n/a−$0.45
Q3 FY25−$0.19n/a−$0.93
Q2 FY25−$0.44n/a−$1.34
Q1 FY25$0.36n/a−$1.56
Q4 FY24−$0.66n/a−$2.76
Q3 FY24−$0.60n/a−$2.94
Q2 FY24−$0.66n/a−$3.54
Q1 FY24−$0.84n/a−$4.14
Q4 FY23−$0.84n/a−$3.96

Against its peers

Companies in Healthcare nearest NEUROONE MEDICAL TECHNOLOGIES' size, closest first, today.

CompanyEPS, 12 monthsGrowth
NMTCNEUROONE MEDICAL TECHNOLOGIES−$0.92
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on NEUROONE MEDICAL TECHNOLOGIES

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.